News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...
Vaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer and BioNTech, one from Moderna — have ...